Home

Drug dilemma

2007-04-23T10:43:00

I was puzzled by David Lock's advice in NICE rulings to PCTs to have a policy to refuse to fund emerging treatments except in exceptional circumstances.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Subscribe

to HSJ

Sign into your account here